Takeshi Inagaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Takeshi Inagaki has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Akira Morino
Department of Physical Therapy, Hokkaido Chitose College of Rehabilitation, Chitose, Japan
1 shared publication - Atsuhito Nakazawa
Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan
1 shared publication - Atsuyoshi Kawagoshi
Department of Rehabilitation Medicine, Akita City Hospital, Akita, Japan
1 shared publication Hideki Katsura
Department of Respirology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan
1 shared publication- Jun Ikari
Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
1 shared publication - Kensuke Kataoka
Department of Respiratory Medicine and Allergy, Tosei General Hospital, 160 Nishioiwake-cho, Seto, Aichi, 489-8642, Japan
1 shared publication
Latest Publications
- Open Access
- 1 May 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (5) , 533
Rehabilitative intervention of frailty for patients with chronic respiratory disease (REINFORCE study): research protocol for a multicentre, randomised controlled trial
Background: Pulmonary rehabilitation, primarily with exercise training, is well-established for patients with chronic obstructive pulmonary disease (COPD); however, rehabilitative intervention specifically targeting physical frailty in patients with chronic respiratory disease (CRD) remains unexplored. This study evaluates a rehabilitative intervention for frailty in older patients with CRDs (REINFORCE), including various lung diseases. Methods: This multicentre, prospective, randomised, controlled trial will enrol 184 patients with CRD. Patients will undergo a 4-week programme focused on addressing declined physical functions, as measured by the Short Physical Performance Battery (SPPB) items such as balance, walking, and/or sit-to-stand chair test. The primary outcome is the change in daily step count as a physical activity measure before and after the programme between the two groups. Secondary outcomes include changes in the SPPB score, peripheral muscle strength (handgrip and quadriceps), 6-minute walk distance (6MWD), and health-related quality of life (HRQL) scores at 4 weeks and 1 year. Discussion: The REINFORCE study is designed to be one of the first randomised trials targeting frailty in CRD and aims to explore the feasibility and potential benefit of a novel intervention to improve physical activity levels. Trial Registration: This randomised controlled trial was prospectively registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) under the registration number UMIN000053979 on June 1, 2024.
- 1 May 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (5) , 533
Open AccessRehabilitative intervention of frailty for patients with chronic respiratory disease (REINFORCE study): research protocol for a multicentre, randomised controlled trial
Background: Pulmonary rehabilitation, primarily with exercise training, is well-established for patients with chronic obstructive pulmonary disease (COPD); however, rehabilitative intervention specifically targeting physical frailty in patients with chronic respiratory disease (CRD) remains unexplored. This study evaluates a rehabilitative intervention for frailty in older patients with CRDs (REINFORCE), including various lung diseases. Methods: This multicentre, prospective, randomised, controlled trial will enrol 184 patients with CRD. Patients will undergo a 4-week programme focused on addressing declined physical functions, as measured by the Short Physical Performance Battery (SPPB) items such as balance, walking, and/or sit-to-stand chair test. The primary outcome is the change in daily step count as a physical activity measure before and after the programme between the two groups. Secondary outcomes include changes in the SPPB score, peripheral muscle strength (handgrip and quadriceps), 6-minute walk distance (6MWD), and health-related quality of life (HRQL) scores at 4 weeks and 1 year. Discussion: The REINFORCE study is designed to be one of the first randomised trials targeting frailty in CRD and aims to explore the feasibility and potential benefit of a novel intervention to improve physical activity levels. Trial Registration: This randomised controlled trial was prospectively registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) under the registration number UMIN000053979 on June 1, 2024.
- 6 February 2026
- Published by Elsevier in Respiratory Investigation
- Vol. 64 (2) , 101380
Effects of olfactory stimulation with L-menthol on sensations of discomfort on exertion in patients with chronic lung diseases
- 6 February 2026
- Published by Elsevier in Respiratory Investigation
- Vol. 64 (2) , 101380
Effects of olfactory stimulation with L-menthol on sensations of discomfort on exertion in patients with chronic lung diseases